Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05797896 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Study acronym: i-GAIN
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 31, 2026 to Jul 31, 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites revised (22)
    v4
  2. Primary and study completion dates: Feb 6, 2025 to Dec 31, 2026v3 Show 4 more changesShow less
    • Study sites: 12 to 22
    • Eligibility criteria expanded, about 94 words
    • Secondary endpoints: 4 to 7
    • Study description revised
  3. Study sites revised (12)v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An observational study to investigate the natural history and evaluate biomarkers of participants with geographic atrophy secondary to age-related macular degeneration
Trial Details
NCT Number NCT05797896
Lead Sponsor Complement Therapeutics
Conditions
(from sponsor)		 Dry Age-related Macular Degeneration, Geographic Atrophy, Retinal Disease, Macular Degeneration, Macular Atrophy, Retinal Degeneration, Eye Diseases
Related terms Anetoderma, Eye Diseases, Geographic Atrophy, Macular Degeneration, Retinal Degeneration, Retinal Diseases
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov